Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study

BACKGROUND: African American breast cancer patients have lower frequency of hormone receptor–positive (HR+)/human epidermal growth factor receptor 2 (HER2)–negative disease and higher subtype-specific mortality. Racial differences in molecular subtype within clinically defined subgroups are not well...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Natl Cancer Inst
Autori principali: Troester, Melissa A., Sun, Xuezheng, Allott, Emma H., Geradts, Joseph, Cohen, Stephanie M., Tse, Chiu-Kit, Kirk, Erin L., Thorne, Leigh B., Mathews, Michelle, Li, Yan, Hu, Zhiyuan, Robinson, Whitney R., Hoadley, Katherine A., Olopade, Olufunmilayo I., Reeder-Hayes, Katherine E., Earp, H. Shelton, Olshan, Andrew F., Carey, Lisa A., Perou, Charles M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059138/
https://ncbi.nlm.nih.gov/pubmed/28859290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djx135
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi